Imatinib in Acute Ischaemic Stroke

Clinical trial NCT03639922 · UNKNOWN

Trial details

NCT number: NCT03639922
Sponsor: Niaz Ahmed
Status: UNKNOWN
Phase: Phase 3
Study type: INTERVENTIONAL

Acute Ischaemic Stroke

Start date: 2018-10-01
Primary completion: 2022-12-01
Enrollment: 1260

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.